Cutter & CO Brokerage, Inc. Incyte Corp Transaction History

Cutter & CO Brokerage, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$66.18 - $83.18 $34,744 - $43,669	-525 Reduced 4.93%	10,133 $770,000
Q1 2022 May 03, 2022	BUY	$66.02 - $79.71 $6,139 - $7,413	93 Added 0.88%	10,658 $846,000
Q4 2021 Feb 10, 2022	BUY	$63.34 - $74.11 $38,004 - $44,466	600 Added 6.02%	10,565 $775,000
Q3 2021 Nov 02, 2021	BUY	$68.67 - $84.02 $54,936 - $67,216	800 Added 8.73%	9,965 $685,000
Q2 2021 Aug 09, 2021	BUY	$79.87 - $87.53 $25,558 - $28,009	320 Added 3.62%	9,165 $771,000
Q1 2021 May 11, 2021	BUY	$76.02 - $100.5 $672,396 - $888,922	8,845 New	8,845 $719,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.6B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.